GM potatoes and the implications for pharma
05 March 2010
Ian Schofield
Genetically modified potatoes might not appear at first sight to be a matter of more than passing interest to observers of the pharmaceutical scene. But the
European Commission's go-ahead this week for cultivation of the first GM potato – also the first GMO authorisation in the EU since 1998 – has...
Please Login to read the full article.
05 March 2010
Ian Schofield
Please Login to read the full article.
RELATED CONTENT
NEWS
- Today Illumina; tomorrow the world? Where the acquisition might really take Roche
- US Capitol Capsule: Obama wants one-stop shop for patents, trade & small biz aid
- ENKAM consortium wins EU funds to advance Alzheimer's programme
- US Supreme Court hears case that could decide future of personalized medicine
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
09 February 2012
London
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
